Generation of stem cell-derived β-cells from patients with type 1 diabetes

Nature Communications

Volumn 7, Issue , 2016, Pages

  Millman, Jeffrey R ^a,b   Xie, Chunhui ^c   Van Dervort, Alana ^d   Gürtler, Mads ^c   Pagliuca, Felicia W ^e   Melton, Douglas A ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^c Harvard University   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Semma Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HUMAN INSULIN; INSULIN;

BIOMARKER; CELLS AND CELL COMPONENTS; DIABETES; DISEASE; DRUG; GLUCOSE; STEM;

ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CELL STRESS; CELL TRANSPLANTATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; STEM CELL; STEM CELL DERIVED BETA CELL; ANIMAL; CELL CULTURE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; INDUCED PLURIPOTENT STEM CELL; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SCID MOUSE; STEM CELL TRANSPLANTATION;

MUS;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; IN VITRO TECHNIQUES; INDUCED PLURIPOTENT STEM CELLS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, SCID; STEM CELL TRANSPLANTATION;

EID: 84966430991     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11463     Document Type: Article

References (33)

1. Bakay, M., Pandey, R. & Hakonarson, H. Genes involved in type 1 diabetes: An update. Genes (Basel) 4, 499-521 (2013).
2. Bergholdt, R. et al. Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes 61, 954-962 (2012).
3. Santin, I. & Eizirik, D. L. Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and beta-cell apoptosis. Diabetes Obes. Metab. 15, 71-81 (2013).
4. Tersey, S. A. et al. Islet beta-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes 61, 818-827 (2012).
5. Dunne, J. L., Overbergh, L., Purcell, A. W. & Mathieu, C. Posttranslational modifications of proteins in type 1 diabetes: The next step in finding the cure> Diabetes 61, 1907-1914 (2012).
6. Ferrannini, E. et al. Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset. Diabetes 59, 679-685 (2010).
7. Polychronakos, C. & Li, Q. Understanding type 1 diabetes through genetics: Advances and prospects. Nat. Rev. Genet. 12, 781-792 (2011).
8. Bellin, M. D. et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am. J. Transplant. 12, 1576-1583 (2012).
9. Pagliuca, F. W. & Melton, D. A. How to make a functional beta-cell. Development 140, 2472-2483 (2013).
10. D'Amour, K. A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534-1541 (2005).
11. D'Amour, K. A. et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24, 1392-1401 (2006).
12. Kroon, E. et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 26, 443-452 (2008).
13. Nostro, M. C. et al. Efficient generation of NKX6-1() pancreatic progenitors from multiple human pluripotent stem cell lines. Stem Cell Rep. 4, 591-604 (2015).
14. Yamada, M. et al. Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature 510, 533-536 (2014).
15. Maehr, R. et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc. Natl Acad. Sci. USA 106, 15768-15773 (2009).
16. Thatava, T. et al. Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Mol. Ther. 21, 228-239 (2013).
17. Pagliuca, F. W. et al. Generation of functional human pancreatic b cells in vitro. Cell 159, 428-439 (2014).
18. Vegas, A. J. et al. Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat. Med. 22, 306-311 (2016).
19. Rezania, A. et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat. Biotechnol. 32, 1121-1133 (2014).
20. Russ, H. A. et al. Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro. EMBO J. 34, 1759-1772 (2015).
21. Kirk, K., Hao, E., Lahmy, R. & Itkin-Ansari, P. Human embryonic stem cell derived islet progenitors mature inside an encapsulation device without evidence of increased biomass or cell escape. Stem Cell Res. 12, 807-814 (2014).
22. Hrvatin, S. et al. Differentiated human stem cells resemble fetal, not adult, beta cells. Proc. Natl Acad. Sci. USA 111, 3038-3043 (2014).
23. Shang, L. et al. Beta-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome. Diabetes 63, 923-933 (2014).
24. Kiskinis, E. et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 14, 781-795 (2014).
25. Cnop, M. et al. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54, S97-S107 (2005).
26. Zhong, J., Rao, X., Xu, J. F., Yang, P. & Wang, C. Y. The role of endoplasmic reticulum stress in autoimmune-mediated beta-cell destruction in type 1 diabetes. Exp. Diabetes Res. 2012, 238980 (2012).
27. Guo, S. et al. Inactivation of specific beta cell transcription factors in type 2 diabetes. J. Clin. Invest. 123, 3305-3316 (2013).
28. Blum, B. et al. Reversal of beta cell de-differentiation by a small molecule inhibitor of the TGFbeta pathway. eLife 3, e02809 (2014).
29. Hua, H. et al. iPSC-derived beta cells model diabetes due to glucokinase deficiency. J. Clin. Invest. 123, 3146-3153 (2013).
30. Li, H. L. et al. Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9. Stem Cell Rep. 4, 143-154 (2015).
31. Burns, S. M. et al. High-throughput luminescent reporter of insulin secretion for discovering regulators of pancreatic Beta-cell function. Cell Metab. 21, 126-137 (2015).
32. Caillat-Zucman, S. et al. TAP1 and TAP2 transporter genes and predisposition to insulin dependent diabetes mellitus. C. R. Acad. Sci. III 315, 535-539 (1992).
33. Bluestone, J. A. et al. Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci. Transl. Med. 7, 315ra189 (2015).